Coley's toxins in perspective (original) (raw)

Nature volume 357, pages 11–12 (1992) Cite this article

Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.

References

  1. Coley, W. B. Practitioner 83, 589–613 (1909).
    Google Scholar
  2. Nauts, H. C. et al. Can. Res. 6, 205–216 (1946).
    CAS Google Scholar
  3. Harmer, T. W. Boston Med. Surg. J. 171, 253 (1914).
    Article Google Scholar
  4. Johnston, B. J. & Novales, E. T. Can. Chem. Rep. No. 21, 43–68 (1962).
  5. Axelrod, R. S. et al. Cancer 61, 2219–2230 (1988).
    Article CAS Google Scholar
  6. Tichatschek, E. et al. Can. Immun. Immunother. 27, 278–282 (1988).
    CAS Google Scholar
  7. Berendt, M. J. et al. J. exp. Med. 148, 1560 (1978).
    Article CAS Google Scholar
  8. Demetri, G. D. et al. J. clin. Oncol. 7, 1545 (1989).
    Article CAS Google Scholar
  9. Spriggs, D. R. & Yates, S. W. in Tumor Necrosis Factors (ed. Beutler, B.) 394 (Raven, New York, 1992).
    Google Scholar
  10. Carswell, E. A. et al. Proc. natn. Acad. Sci. U.S.A. 72, 3666–3670 (1975).
    Article ADS CAS Google Scholar
  11. McIntosh, J. K. et al. Can. Res. 49, 1408–1414 (1989).
    CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Amgen, Inc., 1840 Dehavillard Drive, Thousand Oaks, California, 91320–1789, USA
    Charlie O. Starnes

Authors

  1. Charlie O. Starnes

Rights and permissions

About this article

Cite this article

Starnes, C. Coley's toxins in perspective.Nature 357, 11–12 (1992). https://doi.org/10.1038/357011a0

Download citation